Nina Mikirova, PhD, MS

Orthomolecular Medicine Hall of Fame

Inducted 2020

Nina Mikirova, PhD, graduated from Moscow State University with a Doctorate in physics and mathematics. She also earned a MS degree in statistics and had academic training in biochemistry in the United States. Dr. Mikirova worked for 15 years as the Senior Researcher Chief at the Institute of Bio-Medical Problems in Russia, specializing in the understanding of the physical processes of solar activity and their effects on Earth, as well as in space.

In 1997 Dr. Mikirova joined the Riordan Clinic. At that time the Riordan Clinic concentrated on nontoxic, adjunctive cancer care. The foundation of this project is RECNAC (Research Encompassing Novel Approaches to Cancer, or CANCER spelled backwards) with the goal to reverse the growing trends of cancer by identifying nontoxic adjunctive treatment modalities in the care of cancer patients. The team went on to make many discoveries regarding the use of intermittent high-dose IVC and conducted clinical trials demonstrating the safety and effectiveness of continuous IVC.

Dr. Mikirova has published more than 50 papers in the area of nutrients as biological response modifiers and 50 articles in the area of bio-medical aspects of solar radiation. Her areas of research focus include: the effect of high dosage intravenous vitamin C on inflammation, cytokines, angiogenesis and viral infection; potential of using high dose intermittent and continuous IVC as the adjuvant therapy to treat cancer; effect of nutrients on the levels of progenitor and stem cells in circulation; energy metabolism and functioning of mitochondria in cancer and normal cells; effects of micronutrient supplementation on cardiovascular risk factors; and effectiveness of chelation therapy in clearing toxic heavy metals from the body.

She is a 2014 recipient of the Riordan Clinic’s Pearl Maker award, which recognizes individuals for their actions to further the mission of stimulating an epidemic of health, worldwide. Dr. Mikirova has been invited to to lecture on The Riordan IVC Protocol for Cancer at many prestigious international medical meetings, including in Germany, England, Japan, Ecuador, Peru, Mexico, Morocco, Columbia and Algeria. She has authored and co-authored many papers published in the Journal of Orthomolecular Medicine.

For her dedicated, pioneering research in Orthomolecular Medicine and Oncology, Nina Mikirova was welcomed into the Orthomolecular Medicine Hall of Fame on Friday, September 25, 2020.

 

Dear Colleagues,

This is a very special moment for me. I feel very honoured and privileged to be here with you. For me the love of science began from early childhood. I inherited the love of science from my parents, specifically from my father who was a great scientist.

Shortly after I got my degree in physics and mathematics, I became interested in learning about the nature of the universe, my particular interest was in cosmic rays. Cosmic Rays are protons and electrons that could be described as “the last breath of dying stars.” My original interest in science was far from the field of medicine.

When I came to the United Stated, I was fortunate to meet Dr. Hugh Riordan. He was great doctor, but he was also interested in electrical engineering, specifically in the effect of electromagnetic field on cells and human body. This is where my expertise was beneficial to his research.

To accomplish many of his other projects I took academic training in biochemistry and received a degree in statistics. Now I understand that “Nature and human body are not just the individual subject of biology, chemistry or physics, it is all three disciplines inter-related together including other fields of science.”

I dedicated the rest of my time at the clinic to the evaluation of medical treatments and products that our patients were interested in and also proving that integrative treatments that the clinic was providing had a scientific base.

Things changed, unfortunately. I would like to speak up loudly and clearly about the benefits of research in supporting the efficacy of the alternative treatments. “There is only scientifically proven, evidence-based medicine supported by solid data or unproven medicine, for which scientific evidence is lacking.”

My hope is that alternative medicine will move in direction of scientifically proven methods of treatment in the near future.

Thank you again for recognition of my work.

Nina Mikirova, PhD

---